Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06919419 · ClinicalTrials.gov registry record · NA

HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy

A NA study of HIV and PrEP, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
3,600
Enrollment target
1
Study location

NCT06919419: Recruiting NA study of HIV and PrEP, sponsored by University of Texas Southwestern Medical Center.

NCT06919419 is a NA study of HIV and PrEP that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 3,600 participants, above the 428-participant average among 303 other HIV trials with a reported enrollment target (741% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06919419, a NA study of HIV and PrEP, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
3,600 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to measure the implementation and effectiveness of a multicomponent strategy for PrEP for people who are incarcerated at the Dallas County Jail. Specifically, based on a patients risk score on an electronic medical record HIV prediction model, referrals from providers and/or patient self-referrals, a PrEP patient navigator will meet with individuals at the jail to discuss HIV risk, offer HIV/STI testing if not yet completed and offer education around PrEP with referrals to community-based PrEP providers.

Primary Outcome

Measure the proportion of individuals (of those who stated that they were interested in PrEP and have been released from jail) who attended a clinic visit with a PrEP provider as confirmed by the PrEP patient navigator or through medical record review.

Interventions

  • BEHAVIORAL Multicomponent strategy

Study Locations (1)

Texas

  • Dallas County Jail - Dallas

Trial Details

FieldValue
Enrollment Target 3,600 participants
Start Date 2025-03-01
Est. Completion 2027-08-31
Phase NA

What NCT06919419 shows while recruiting

NCT06919419 is an interventional study that assigns participants to a tested intervention. Its 3,600 participants enrollment target places it among the larger protocols in the corpus, above the 428-participant average among 303 other HIV trials with a reported enrollment target (741% higher).

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Multicomponent strategy is the first listed.

NCT06919419 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06919419 about?

NCT06919419 is a clinical study titled "HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy". The goal of this study is to measure the implementation and effectiveness of a multicomponent strategy for PrEP for people who are incarcerated at the Dallas County Jail. Specifically, based on a patients risk score on an electronic medical record HIV prediction model, referrals from providers and/o...

What is the current status of trial NCT06919419?

This trial is currently recruiting. It is a NA study. The enrollment target is 3,600 participants. The study started on 2025-03-01. Estimated completion is 2027-08-31.

What conditions does trial NCT06919419 study?

This clinical trial studies the following conditions: HIV, PrEP, Incarceration.

What interventions are being tested in trial NCT06919419?

The interventions under investigation include: Multicomponent strategy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06919419?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06919419 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06919419's enrollment target sits among peer trials

3,600 6th of 303 higher than 298 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06088498 · 3,600 participants · Phase 2

    App for Reducing Cravings to Smoke

  • NCT06501118 · 3,600 participants · NA

    Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients

  • NCT07091032 · 3,600 participants · NA

    Building Connections

  • NCT03199651 · 3,584 participants · NA

    Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06919419, the US trial registry maintained by the National Library of Medicine. NCT06919419 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.